DDW 2022 Conference Coverage
Playback speed
10 seconds
Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab and Infliximab in Biologic-Naive Patients With Ulcerative Colitis
By
DDW 2022 Conference Coverage
FEATURING
Rahul Dalal
By
DDW 2022 Conference Coverage
FEATURING
Rahul Dalal
111 views
June 7, 2022
Comments 0
Login to view comments.
Click here to Login
Videos